baber/WOPTO huggingface dataset:
Patent NZ-573425-A (NZ)
Title: Fkbp-l and uses thereof
Inventor: ROBSON TRACY
IPC: A61P35/00
Filed: 2007-06-08
Abstract: Disclosed is the use of (i) an active compound comprising an isolated FKBP-L polypeptide or a biologically active fragment of a FKBP-L polypeptide, or a biologically active derivative of a FKBP-L polypeptide or fragment thereof or (ii) a polynucleotide encoding such a biologically active FKBP-L polypeptide, fragment or derivative in the manufacture of a medicament for use in treating a disorder mediated by or associated with angiogenesis, or for use in the treatment of angiogenesis-associated inflammation, or for use in the treatment of ocular disorders mediated by angiogenesis, wherein the biologically active derivative of a FKBP-L polypeptide comprises an amino acid sequence at least 70% identical to the amino acid sequence shown in any one of SEQ ID NOs 1 to 28.
Patent NZ-574524-A (NZ)
Title: Piston assembly for positioning lumen of a reservoir for an osmotic delivery having a columnar body and a spring
Inventor: ALESSI THOMAS R
IPC: A61M31/00
Filed: 2007-08-08
Abstract: An osmotic delivery system (100) comprising a reservoir (102) with a lumen (104) and a piston assembly (200) is disclosed. The body (202) of the piston assembly (200) is constructed and arranged for positioning in the lumen (104). The body (202) is made of a selected group of polymeric material that is resistant to leaching in the presence of a selected group of organic solvents. The body (202) of the piston assembly (200) is a columnar body comprising a rim (206) at a distal end for engaging and sealing against the wall of the reservoir (102). There is a spring (210) retained at the distal end for biasing the rim (206) against the wall of the reservoir (102).
Patent NZ-574621-A (NZ)
Title: Phenyl substituted heteroaryl-derivatives and use thereof as anti-tumour agents
Inventor: STEURER STEFFEN
IPC: C07D401/12
Filed: 2007-07-05
Abstract: Disclosed is a triazole substituted phenyl compound of formula (I) where the substituents are as disclosed in the specification. Also disclosed is a pharmaceutical composition comprising a compound of formula (I) and the use of a compound of formula (I) in the preparation of a pharmaceutical composition for the treatment and or prevention of cancer, infections, inflammation and autoimmune diseases.
Patent NZ-574674-A (NZ)
Title: A solar power generator working through a heated air engine
Inventor: ZAVTRAK SERGUEI
IPC: F24S23/00
Filed: 2009-07-19
Abstract: A solar electric power generator. A spherical transparent ball filled with a transparent liquid focuses sunlight onto a shaped, concave container (3) containing an inlet valve (19) and an outlet valve (12). The concentrated sunlight heats the air inside the container. The expansion of the heated air is directed through the outlet valve to a hot air engine (8) which uses the oscillatory nature of the airflow determined by the outlet valve to move a piston (10) and magnet (16) and generate electric current through induction in coil (17).
Patent NZ-577414-A (NZ)
Title: A method for manufacturing cheese melt bodies for food articles and cheese melt bodies for food articles
Inventor: VAN DER DRIFT ANTONY BENJAMIN
IPC: A23L13/60
Filed: 2007-12-13
Abstract: Discloses a method of manufacturing cheese melt bodies for use in the preparation of bread products incorporating melt bodies, the method includes: (i) providing at least one cheese component mixed with at least one other food component to form a substantially homogeneous cheese mixture; (ii) separating discrete portions of cheese mixture from the cheese mixture; (iii) forming each portion of the cheese mixture into a disk shape wherein each disk shaped melt body has a thickness of 5 to 10 mm and a mass of 10-40 grams The cheese melt body may be formed under specific temperatures and may be frozen. Further disclosed are the food components which may be bacon pieces or cheese particulates or other edible components. Further disclosed is a method of making a cooked food article involving the use of the cheese melt body.
Patent NZ-583067-A (NZ)
Title: Closure means with a dish which recieves a rotary latch mechanism designed to reduce leakage
Inventor: STUCKEY DAVID MARTIN
IPC: B60R9/048
Filed: 2008-08-13
Abstract: Disclosed is a closure means comprising a dish, having a perimeter flange, at least one side wall, a dish floor and a recessed area defined by the at least one side wall and the dish floor; and a latching mechanism comprising a non-rotatory outer housing and a rotatable inner actuator; and an opening formed in the dish floor of suitable size and shape to receive at least a part of said latching mechanism there through, wherein the latching mechanism comprises a non-rotatory outer housing and a rotatable inner actuator and wherein any gap existing between the opening and the latching mechanism is substantially reduced to minimise any fluid leakage there through.
Patent NZ-583264-A (NZ)
Title: Aerodynamic drag reducing led floodlight fixture
Inventor: RUUD ALAN J
IPC: F21V15/01
Filed: 2008-07-10
Abstract: An LED floodlight fixture (10) has two major principal axes in a fixture plane, the dimensions parallel to the fixtures third principal axis being substantially smaller than the largest dimensions parallel to the fixture plane. The fixture (10) is characterized by a first outer surface (18) which has a first central portion (20) and a first edge-adjacent portion (22), an opposite second outer surface (24) which has a second central portion (44) and a second edge adjacent portion (28). The second central portion (44) is substantially aligned with the first central portion (20) and encompasses a light-emitting region (26). The second edge-adjacent portion has a boundary (46) with the second central portion (44) that defines a reference plane (34). The first and second edge-adjacent portions (22, 28) meet at a perimetrical edge (30) and the first and second central portions extend across at least 25% of the area within the perimetrical edge (30). The edge-adjacent regions (22, 28) are substantially convex and form aerodynamic drag-reducing cross sections in planes transverse the fixture plane with aspect ratios of about 3 or less. The greatest distance between the first (20) and second (44) central portions is no more than 50% greater than the smallest distance therebetween.
Patent NZ-584911-A (NZ)
Title: Improved nogo-a binding molecules and pharmaceutical use thereof
Inventor: BARSKE CARMEN
IPC: A61K39/00
Filed: 2008-10-27
Abstract: Disclosed is an isolated binding molecule comprising at least one antigen binding site which specifically binds tot eh human NogoA polypeptide or human NIG. Also disclosed is a polynucleotide encoding the binding molecule and methods of producing the binding molecule. The binding molecule can be used in the manufacture of a medicament to treat diseases of the peripheral and central nervous system.
Patent NZ-585061-A (NZ)
Title: Respiratory devices and methods of use
Inventor: HATANAKA MOTOHIDE
IPC: A61M16/00
Filed: 2005-12-08
Abstract: A nasal respiratory mask device for modifying a subject's respiration. The device includes a nasal mask 108 that is secured at least partially over the subject's nose and an airflow resistor coupled to the mask that offers more resistance to air exhaled through the device than to air inhaled through the device. The device is held in place, at least partially over the subject's nose, by a holdfast comprising one or more straps 110a 110b. (62) Divided Out of 556274
Patent NZ-586666-A (NZ)
Title: Estradiol-containing drug delivery system
Inventor: FUNKE ADRIAN
IPC: A61K31/565
Filed: 2009-02-05
Abstract: Disclosed is a unit dosage form comprising a thin water-soluble film matrix, wherein (a) said film matrix comprises at least one water-soluble matrix polymer; (b) said film matrix comprises 10-200 micrograms of estradiol, or a therapeutically equivalent amount of a hydrate of estradiol or a therapeutically equivalent amount of a pharmaceutically acceptable ester of estradiol; and (c) said film matrix has a thickness of less than 300 micrometres, wherein the estradiol, hydrate of estradiol, or ester of estradiol is present in the unit dosage form in non-complexed form. Said dosage form is suitable for treating a physical condition selected from the group consisting of osteoporosis, headaches, nausea, depression, vasomotor symptoms (such as hot flushes, sweating attacks including night sweats, and palpitations), symptoms of urogenital atrophy, decrease in bone mineral density, and increased risk or incidence of bone fracture
Patent NZ-587137-A (NZ)
Title: A method of inducing tolerance to an allergen a method of inducing tolerance to an allergen
Inventor: TANG MIMI LAI-KUAN TANG MIMI LAI-KUAN
IPC: A61K39/39
Filed: 2009-01-30
Abstract: 587137 Disclosed is the use of a probiotic compris587137 Disclosed is the use of a probiotic comprising a live Lactobacillus species selected from theing a live Lactobacillus species selected from the list consisting of Lactobacillus rhamnosus, Lacto list consisting of Lactobacillus rhamnosus, Lactobacillus acidophilus NCFM, Lactobacillus casei, Labacillus acidophilus NCFM, Lactobacillus casei, Lactobacillus casei Shirota, Lactobacillus casei immctobacillus casei Shirota, Lactobacillus casei immunitass, Lactobacillus johnsonii, Lactococcus lactunitass, Lactobacillus johnsonii, Lactococcus lactis, Lactobacillus plantarum, Lactobacillus reuteriis, Lactobacillus plantarum, Lactobacillus reuteri, Lactobacillus salivarius and Lactobacillus helve, Lactobacillus salivarius and Lactobacillus helvetirus and a food allergen inducing an allergic reatirus and a food allergen inducing an allergic reaction in a subject sensitive to the allergen in thction in a subject sensitive to the allergen in the manufacture of a medicament for allergen-specifie manufacture of a medicament for allergen-specific tolerance induction to the allergen in a subjectc tolerance induction to the allergen in a subject. Further disclosed is a method for inducing toler. Further disclosed is a method for inducing tolerance to a food allergy in a non-human subject saidance to a food allergy in a non-human subject said method comprising administering sequentially or s method comprising administering sequentially or simultaneously to said non-human subject a probiotiimultaneously to said non-human subject a probiotic Lactobacillus rhamnosus, Lactobacillus acidophilc Lactobacillus rhamnosus, Lactobacillus acidophilus NCFM, Lactobacillus casei, Lactobacillus casei us NCFM, Lactobacillus casei, Lactobacillus casei Shirota, Lactobacillus casei immunitass, LactobaciShirota, Lactobacillus casei immunitass, Lactobacillus johnsonii, Lactococcus lactis, Lactobacillus llus johnsonii, Lactococcus lactis, Lactobacillus plantarum, Lactobacillus reuteri, Lactobacillus saplantarum, Lactobacillus reuteri, Lactobacillus salivarius and Lactobacillus helvetirus and a food alivarius and Lactobacillus helvetirus and a food allergen inducing an allergic reaction in a non-humllergen inducing an allergic reaction in a non-human subject sensitive to the allergen in an amount an subject sensitive to the allergen in an amount effective to induce allergen-specific tolerance toeffective to induce allergen-specific tolerance to the allergy.                                      the allergy.
Patent NZ-589859-A (NZ)
Title: A method of spraying viscous glyphosate by flowing a kinetic energy fluid against the glyphospate at a rate sufficent to break the glyphospate into drops
Inventor: EASTIN JOHN ALVIN
IPC: A23L27/00
Filed: 2006-04-18
Abstract: A method of spraying viscous glyphosate comprises the steps of loading the viscous glyphosate onto a spray vehicle, providing a source of kinetic-energy fluid on the spray vehicle and applying the kinetic energy fluid and the viscous glyphosate to a fixture. The kinetic energy fluid is flown against the viscous glyphosate at a flow rate sufficient to break the glyphosate into drops which are sprayed onto an agricultural field from the fixture.
Patent NZ-590981-A (NZ)
Title: Transdermal therapeutic system (TTS) for administration with a wafer
Inventor: HILLE THOMAS
IPC: A61K9/70
Filed: 2006-02-14
Abstract: Disclosed is a use of an analgesic compound for the manufacture of a combination of medicaments, comprising: (a) at least one transdermal therapeutic system (TTS) containing a first analgesic compound selected from the group of opioids and their salts; and (b) at least one wafer for oral administration containing the same analgesic compound selected from the group of opioids and their salts, suitable for the same indication, wherein the amount of analgesic compound contained in the wafer corresponds to 0.1 to 0.7 times the transdermally administered daily dose, wherein said TTS contains as analgesic compound buprenorphine base and said wafer contains as analgesic compound buprenorphine hydrochloride, said wafer contains 10 percent by weight of buprenorphine hydrochloride in a polymer mixture of 65 percent by weight of polyacrylic acid and 25 percent by weight of starch such that the wafer disintegrates in the mouth within about 5 to 10 seconds, for treating a patient who depends on the administration of said analgesic compound in order to achieve a long-term therapy or basic therapy, preferably for achieving a lasting relief from pain.
Patent NZ-591716-A (NZ)
Title: A harvesting machine which can place the harvest in different containers depending on the location by using two sets of conveyors
Inventor: BERTHET JEAN-PAUL
IPC: A01D91/04
Filed: 2009-10-06
Abstract: A harvesting machine comprising a motorised support structure on which are mounted a harvesting assembly adapted to deliver a stream of harvested produce, at least two receptacles 1 d, 1 g for storage of the stream, and a system for feeding a respective receptacle with the stream. The harvesting machine further comprises a device for determining the location of the harvesting machine in the parcel of land the machine is harvesting, where the parcel is divided into geographical areas, a device for determining the area corresponding to the location, and a device that is adapted, as a function of the determined area to automatically control the feeding system to store the harvested stream coming from the area in the receptacle that is dedicated to it. The feeding system comprises upper conveyors 3g, 3d for feeding the receptacles 1g, 1d on respective feed paths with a harvested stream coming from the harvesting assembly, a lower conveyor 6 for feeding a respective receptacle 1g, 1d as a function of the conveying direction, and a device for guiding the harvested stream that for each feed path, is variable between an open state wherein the stream passes along the feed path, and a closed state wherein the stream is diverted onto the lower conveyor 6. The control device is operable to impose the open or closed state of the device for guiding the stream and the conveying direction of the lower conveyor 6 as a function of the receptacle 1g, 1d to be fed with the stream.
Patent NZ-593969-A (NZ)
Title: Pyrazine derivatives useful as inhibitors of atr kinase
Inventor: DURRANT STEVEN
IPC: A61K31/497
Filed: 2009-12-18
Abstract: 593969 Disclosed is a substituted pyrazine compound of formula (I) where the substituents are as disclosed in the specification. Examples of a compounds of formula (I) are: 5-[4-isopropylsulfonyl-3-(trifluoromethoxy)phenyl]-3-[5-[4-(methylaminomethyI)phenyl]-1,3,4-oxadiazol-2-yl]pyrazin-2-amine; 5-(4-isopropylsulfonylphenyl)-3-[3-[2-methyl-4-(methylaminomethyl)phenyl]isoxazol-5-yl]pyrazin-2-amine and 3-[5-[2-fluoro-4-(methylaminomethyl)phenyl]-1,3,4-oxadiazol-2-yl]-5-(4-sec-butylsulfonylphenyl)pyrazin-2-amine. Also disclosed are pharmaceutical compositions comprising a compound of formula (I) and the use of a compound of formula (I) in the manufacture of a medicament. The medicament is useful in the inhibition of ATR and in treating cancer.
Patent NZ-599561-A (NZ)
Title: Compositions and methods for the prevention and treatment of autoimmune conditions
Inventor: SANTAMARIA PERE
IPC: A61K39/00
Filed: 2008-05-07
Abstract: Disclosed are compositions and methods for the prevention and treatment of autoimmune conditions by selectively reducing or expanding T cells according to the antigenic specificity of the T cells. Therefore, the present invention can be used to reduce or eliminate pathogenic T cells that recognize autoantigens, such as beta cell specific T cells. As such, the present invention can be used to prevent, treat or ameliorate autoimmune diseases such as IDDM. Furthermore, the present invention can be used to expand desirable T cells, such as anti-pathogenic T cells to prevent, treat and/or ameliorate autoimmune diseases.
Patent NZ-600403-A (NZ)
Title: Enzymatic wound debriding compositions with enhanced enzymatic activity
Inventor: AUST DUNCAN
IPC: A61L15/38
Filed: 2010-12-08
Abstract: 600403 Disclosed herein are topical enzymatic wound debriding compositions with enhanced enzymatic activity. These compositions comprise a dispersed phase comprising at least one proteolytic enzyme and at least one hydrophilic polyol; and a continuous phase comprising a hydrophobic base wherein the amount of liquid hydrophilic polyol is within ±10% of the optimum amount. Additional disclosed is a method of determining said optimum amount, and a method for increasing enzymatic activity by using said optimum amount.
Patent NZ-602111-A (NZ)
Title: Extended release formulations of rasagiline and uses thereof
Inventor: LIVNAH NURIT
IPC: A61K31/135
Filed: 2011-02-03
Abstract: Disclosed herein is a pharmaceutical composition comprising a pharmaceutically acceptable carrier and an active agent selected from R-(+)-N-propargyl-1-aminoindan (rasagiline), S-(-)-N-propargyl-1-aminoindan, or a pharmaceutically acceptable salt thereof, formulated for extended release of said active agent. Additionally disclosed is an extended release pellet, a method of preparing said pellet and the use in the treatment of a neurodegenerative disease or an injury to the nervous system.
Patent NZ-614086-A (NZ)
Title: Auto-injector
Inventor: EKMAN MATTHEW
IPC: A61M5/32
Filed: 2012-02-16
Abstract: An auto-injector (1) for administering a dose of a liquid medicament (M) is disclosed. The auto-injector including a tubular chassis (2) and a carrier subassembly comprising a tubular carrier (7) slidably arranged partially inside the chassis (2). The carrier (7) is adapted to contain a syringe (3) with a hollow injection needle (4), a drive spring (8) and a plunger (9) for forwarding load of the drive spring (8) to a stopper (6) of the syringe (3). The syringe (3) is lockable for joint axial translation with the carrier (7). A control spring (19) is arranged around the carrier (7). A needle insertion control mechanism (24) couples a proximal end of the control spring (19) to either the carrier (7) for advancing it for needle insertion or to the chassis (2) for needle retraction depending on the relative axial position of the carrier (7) and the chassis (2). The needle insertion control mechanism (24) comprises a first collar (20) biased by the control spring in a proximal direction (P), whereon at least one resilient beam is proximally arranged. Respective recesses are arranged in the carrier (7) and case (2), wherein a transversal extension of a head of the resilient beam (20. 1) is wider than a gap between the carrier (7) and the chassis (2), causing the head of the resilient beam to abut a distal face on the recess in the chassis (2) while being prevented from deflecting in an inward direction (I) by the carrier (7) or to abut a distal face on the recess in the carrier (7) while being prevented from deflecting in an outward direction (O) by the chassis (2) thereby forwarding load from the control spring (19) to the carrier (7) for needle insertion. The resilient beam is arranged to be switched between the chassis (2) and the carrier (7) by ramped engagement of the head to the distal faces under load of the control spring (19) depending on the relative longitudinal position between the chassis (2) and the carrier (7).
Patent NZ-618613-A (NZ)
Title: Fungicide pyrazole carboxamides derivatives
Inventor: HARTMANN BENOIT
IPC: C07D401/12
Filed: 2010-05-12
Abstract: Disclosed herein are pyrazole carboxamides derivatives of formula (1) wherein the variables are defined in the specification, processes for preparation of said derivatives, use of said derivatives as fungicide, and/or anti-mycotoxin active agents, and/or insecticide, and/or nematicide, particularly in the form of fungicide compositions, and methods for the control of phytopathogenic fungi, notably of plants, using these compounds or compositions.
Patent NZ-630711-A (NZ)
Title: Effective animal stunning
Inventor: RALPH JAMES HENRY
IPC: H03H7/40
Filed: 2013-11-04
Abstract: Disclosed are an animal stunning apparatus and method for inducing rapid unconsciousness and insensibility. The apparatus includes a stunning station (10) in which a live subject animal is located in a confined position and an applicator (60) contacts an application point (51) on the live subject animal’s head (50) immediately overlying a frontal portion of the animal’s brain and couples microwave radiation to the head, A microwave generator (75) generates microwave energy of a suitable power level and frequency, and a waveguide (76) directs the microwave radiation to the applicator (60). An auto-tuner (90) in the waveguide uses a directional coupler (91) to detect forward and reflected power and to tune in real time the impedance for matching the load and optimising effective power transfer. A switch (78) discontinues the application of microwave radiation which is heating of the frontal portion of the brain after a period of time sufficient to have raised the temperature of the frontal portion of the brain of the subject animal to thereby induce the unconsciousness and insensibility. Effective measures for optimising the microwave absorption include special constructions of the applicator (63, 66) and sensor switches (67), (68) to minimise microwave leakage. The period can be sufficient only to rapidly induce insensibility, and is insufficient for the insensibility induced to be irreversible, and insufficient to cause significant heating of deeper brain tissues and including the brain stem.
Patent NZ-700703-A (NZ)
Title: Generator for a gearless wind power installation
Inventor: GIENGIEL WOJCIECH
IPC: H02K7/18
Filed: 2013-05-15
Abstract: The invention concerns a generator for a gearless wind power installation. Since the aerodynamic rotors of modern windpower installations turn relatively slowly, generators used in a gearless wind power installation need to have a large diameter. However, this leads to problems in transporting, and mounting the generators on supporting structures due to the weight of known generators, which typically include copper windings. The present invention proposes to solve this problem with a generator for a gearless wind power installation with a stator and a runner, whereby the stator and/or the runner have windings made of aluminum and the generator has an air gap diameter greater than 4.3m.